# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) and Vectura Fertin Pharma, Inc., an innovator i...
Aurora Cannabis Inc. ("Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canadian-based global medical cannabis company, and V...
In late July, nearly three months after New York Governor Kathy Hochul fired Chris Alexander, the former head of the state'...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has scheduled a conference call to discuss the results for its first quarter 2025...
Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has been granted two licenses by the Federal In...
Canaccord Genuity analyst Matt Bottomley maintains Aurora Cannabis (TSX:ACB) with a Buy and raises the price target from C$8...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced on Thursday its financial and operational results for the fourth quarte...